Proteomic characterization of novel histone post-translational modifications by Anna M Arnaudo & Benjamin A Garcia
Arnaudo and Garcia Epigenetics & Chromatin 2013, 6:24
http://www.epigeneticsandchromatin.com/content/6/1/24REVIEW Open AccessProteomic characterization of novel histone
post-translational modifications
Anna M Arnaudo1,2 and Benjamin A Garcia1*Abstract
Histone post-translational modifications (PTMs) have been linked to a variety of biological processes and disease
states, thus making their characterization a critical field of study. In the last 5 years, a number of novel sites and
types of modifications have been discovered, greatly expanding the histone code. Mass spectrometric methods are
essential for finding and validating histone PTMs. Additionally, novel proteomic, genomic and chemical biology
tools have been developed to probe PTM function. In this snapshot review, proteomic tools for PTM identification
and characterization will be discussed and an overview of PTMs found in the last 5 years will be provided.
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Introduction
Nearly 50 years ago Vincent Allfrey described histone
acetylation [1]. Since then research has been focused on
identifying and mapping a growing list of histone post-
translational modifications (PTMs), including lysine
acetylation, arginine and lysine methylation, phosphor-
ylation, proline isomerization, ubiquitination (Ub), ADP
ribosylation, arginine citrullination, SUMOylation, car-
bonylation and, with some controversy, biotinylation
[2]. While PTMs are found on all five histones, they
commonly map to histone N-terminal tails [3]. Func-
tional characterization of these PTMs have implicated
them in a variety of cellular processes including, but not
limited to, transcription, DNA damage, apoptosis, and
cell-cycle regulation [4]. In addition, histone-modifying
enzymes are popular drug targets because they are
misregulated in diseases such as cancer [5]. Histone
PTMs impact biological processes in a number of ways.
PTM acquisition or resulting changes in net charge can
alter DNA-histone or inter-nucleosomal contacts, thereby
modulating chromatin structure [6]. Alternatively, PTMs
can act as a docking site for proteins containing specific
structural domains - for example, chromodomains bind
methylated lysines and bromodomains bind acetylated* Correspondence: bgarci@mail.med.upenn.edu
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distribution, and reproduction in any mediumlysines [6,7]. The recruitment or repulsion of these pro-
teins impacts downstream processes. The idea that PTMs
constitute a code that is read by effector proteins is the
basis for the histone code hypothesis [8,9]. Mass spec-
trometry (MS) has become an essential tool for deci-
phering this code, in part by identifying novel PTMs. In
this review we will focus on MS and proteogenomic
methods involved in identifying and characterizing novel
sites and types of histone PTMs. Additionally, we will
highlight the modifications that have been discovered in
the last 5 years and have greatly added to the modifica-
tions listed above.Identification of novel post-translational modifications by
mass spectrometry
In the search for novel modifications, MS has an advan-
tage over other methods because no prior knowledge of
the modification site or type is required. In traditional
bottom-up analysis, proteins are digested to peptides
with a protease like trypsin, peptides are separated using
liquid chromatography (LC), subjected to MS for peptide
identification, and then fragmented by MS/MS for pep-
tide sequencing (for a basic review, see [10]). PTMs in-
duce a mass shift (+14 Da for methyl, +42 Da for acetyl)
that is detectable in the MS and MS/MS spectra [11].
Multiple software algorithms have been developed to de-
tect and map modifications from MS and MS/MS data
with varying degrees of success.Central Ltd. This is an Open Access article distributed under the terms of the
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bottom-up MS techniques is challenging because his-
tones are both lysine and arginine rich. Trypsin diges-
tion results in short peptides that are incompatible
with LC-MS and peptides of inconsistent length due to
variable cleavage at modified residues (in other words,
trypsin will cleave at mono-, but not di- or tri- methyl-
ated lysines) [12,13]. Chemical derivatization strategies
can help overcome these challenges. Propionic anhy-
dride derivatization results in cleavage only at the C-
terminal of arginine, increasing sequence coverage and
generating larger, consistently cleaved peptides [13].
These strategies therefore aid in discovering and quantify-
ing histone PTMs. In addition to bottom-up strategies,
middle-down and top-down strategies have been created
to facilitate PTM discovery and explore combinatorial his-
tone codes. Top-down utilizes whole histone protein [14],
while middle-down utilizes alternative protease digestions
to create large peptide fragments [15,16]. Both of these
strategies rely on electron transfer dissociation (ETD), an
MS/MS technique that is more suitable for fragmentation
of highly charged, larger peptides [17].
Due to the highly modified nature of histones and the
numerous PTM combinations that can result, reliably
assigning modifications to histone peptides can be diffi-
cult. Algorithms have been designed to specifically map
histone modifications and identify novel sites of modifica-
tion [18-21]. For unbiased novel PTM type discovery,
Chen and colleagues [18] developed PTMap to explore a
wide window of mass shifts in small increments and iden-
tify unique modifications. It also decreases false positives
by scoring unmatched peaks in the MS/MS spectra [18].
Misidentification of novel histone PTMs can come from
a variety of sources including isobaric mass shifts due to
histone sequence variation or other modifications, sample
preparation, gas phase chemistry within the mass spec-
trometer, and false positives or incorrect database assign-
ments [22]. In the case of methylation, for example, the
use of methanol during sample processing can result in
methylation of aspartic or glutamic acid [23]. Methyl
transfer within a peptide has also been observed on singly
charged peptides in the gas phase, which could ultimately
result in a false positive methylation site assignment [24].
Modifications can also be lost during sample processing
or MS analysis due to their chemical, enzymatic and/or
MS/MS lability. Histidine phosphorylation was discovered
on histones in the 1970s [25,26], but has been difficult to
study by MS because it is acid labile and can be lost during
sample processing [27]. Serine/threonine phosphorylation
and O-glycosylation are susceptible to loss during sample
preparation by enzymatic removal and during MS/MS
fragmentation by collision induced dissociation [28,29].
Alternative fragmentation with ETD has been suggested
to aid detection of labile modifications [17].To be confident of a novel PTM, experimental con-
firmation is required. Heavy isotope labeling in cell cul-
ture with the modification donor can be used to
confirm that it is acquired in vivo rather than during
sample preparation. Such experiments have recently
been used to probe sites of methylation using heavy me-
thyl donor 13CD3- S-adenosylmethionine [22] and the
presence of crotonylation using heavy D4 crotonate
[30]. Pan-modification or site-specific antibodies are
also commonly raised to test the in vivo presence of the
modification [30]. Pan-modification antibodies have the
added benefit that they can be used to probe all the core
histones across multiple organisms. Traditionally, the
standard for verification is the generation of a synthetic
peptide containing the PTM of interest. MS/MS frag-
mentation and LC elution patterns from the in vivo
derived peptide, the synthetic peptide and a mixture of
the two are compared to confirm the site and type of
modification [22,31]. Recent reports on the misidentifi-
cation of serine methylation on histone H3S28 [22] and
threonine acetylation on histone H2AT15 [31], however,
indicate that synthetic peptides can be insufficient and
suggest that further fragmentation (MS3) is necessary
for confirmation.
Novel sites and types of modifications
In the last 5 years, a number of novel sites and types
of PTMs have been discovered. A comprehensive list
can be found in Figure 1. The novel types of modifica-
tions include tyrosine hydroxylation [30], serine and
threonine acetylation [32], lysine crotonylation (Kcr)
[30], lysine N-formylation [33], lysine succinylation
[34], lysine malonylation [34], lysine propionylation
[35], lysine butyrylation [35], O-GlcNAcylation (beta-
N-acetylglucosamine) [36-38], lysine 5-hydroxylation
[39] and cysteine glutathionylation [40]. Novel sites in-
clude Ub [41], phosphorylation [42,43], ADP-ribosylation
[44], lysine acetylation and mono-, di- and tri- lysine
methylations [30,45]. The degree of characterization varies
for each PTM identified; however, there are some interest-
ing findings and themes that emerge.
One interesting trend is the prevalence of PTMs
discovered in new areas of the histone protein. While ca-
nonical histone Ub is present in the C-termini of H2A
and H2B, novel Ub sites have been mapped to the N-
terminus of H2A at H2AK13 and K15. LC-MS/MS
analysis confirmed the presence of Ub at both sites,
which are contained on a single peptide. Functional ana-
lyses indicate these sites are present during the DNA
damage response to double strand breaks and their
modification is controlled by E3 ubiquitin ligase RNF168
[41]. A multitude of PTMs have been found on the
histone globular domains, raising questions about how
these modifications impact nucleosomal structure and
Figure 1 Recently identified modifications on the core histones. Black, modifications found in vivo in human; red, modifications found
in mouse brain; blue, modifications found in vitro. ac, acetylation; Ar, ADP-ribosylation; bu, butyrylation; cr, crotonylation; fo, formylation;
gt, glutathionylation; ma, malonylation; me, methylation; Og, O-glcNAcylation; oh, hydroxylation; pr, propionylation; su, succinylation;
ph, phosphonylation; ub, ubiquitination.
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fied on H2BY83 and H4Y88 in a MS screen for novel
modifications using PTMap. Since these residues are
located near the H2B-H4 contact, they may play a role
in altering chromatin structure via intranucleosomal
surface contacts [30]. Phosphorylation within the globu-
lar domain may also impact structure [43,46]. A novel
site was identified at H3T45 by MS. Protein kinase C-
gamma phosphorylation of this residue increases during
apoptosis and any resulting change to nucleosomal
structure may promote DNA fragmentation common to
apoptosis [43]. Novel PTM glutathionylation of histone
H3C110 was shown to destabilize nucleosomes by ther-
mal stability tests [40]. Interestingly, global PTMs can
also affect binding of reader proteins, a role typically as-
sociated with PTMs on histone tails. A novel phosphor-
ylation site at H3Y41 was found with an antibody. Janus
kinase 2 (JAK2) phosphorylates H3Y41, which when
phosphorylated could act to ameliorate transcriptional
repression of JAK2-controlled genes by preventing bind-
ing of HP1alpha [42,47].
A link between cellular metabolism and histone modi-
fication is another trend found within novel PTMs. N-formylation of lysine is thought to arise from oxidation.
Deoxyribose oxidation can create a 3’-formylphosphate,
which is free to attack lysine and create N-formyl-lysine
[33]. LC-MS/MS analysis using high mass accuracy to
differentiate formylation and di-methylation shows that
N-formyl-lysine can occur on all five histones, at sites
that are commonly methylated or acetylated [48]. Com-
petition of N-formylation with other modifications for
lysine residues could be a way DNA oxidation resulting
from cellular metabolism can impact PTM-mediated
cellular processes [33]. Another way that metabolism
affects PTM acquisition is through the use of different co-
enzyme A (CoA) molecules as PTM donors. This link has
been well established for acetyl-CoA and lysine acetyl-
ation. More recently, lysine propionylation and butyry-
lation were identified on histone H4 by LC-MS/MS and
confirmed using synthetic peptides. In vitro experiments
showed that known histone acetyltransferases (HATs) [46]
CBP and p300 lysine were able to catalyze reactions using
radioactive propionyl-CoA and butyryl-CoA as donors for
lysine propionylation and butyrylation, respectively. Since
propionyl-CoA and butyryl-CoA are derived from differ-
ent metabolic processes and levels fluctuate across
Figure 2 Global domain post-translational modifications. (a) The nucleosome with H3 (blue), H4 (green), H2A (red) and H2B (yellow).
(b) Tryosine hydroxylation on H2BY83 (cyan) and H4Y88 (purple) occur at the H2B:H4 interface. (c) Glutathionylation of H3C110 mapped to the
H3:H4 tetramer interface. (d) Phosphorylation on H3T45 (pink) and H3Y41 (yellow) mapped to the H3:H4 tetramer. (e) Phosphorylations from
(d) occur near the H3:DNA contact.
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suggest that these modifications may play a role in regu-
lating cellular metabolism [35]. A separate study also iden-
tified lysine succinylation and lysine malonylation, using
affinity enrichment with anti-succinyllysine and anti-
malonyllysine antibodies in combination with LC-MS/MS
analysis. Since succinyl-CoA and malonyl-CoA are also
metabolic intermediates, these may also link metabolism
with histone PTMs [34]. Further studies on all these CoA-
related PTMs are needed to determine how they are
established in vivo and what processes they regulate.
One novel lysine modification, Kcr, has been relatively
well characterized. It was discovered by a characteristic
68 Da mass shift by LC-MS analysis and confirmed
using synthetic peptides. In the genome, Kcr localizes to
potential enhancers and to promoters, showing enrich-
ment at transcription start sites [30]. One functional role
for this modification is in haploid male germ cell differen-
tiation. Kcr was found at active genes on the sex chro-
mosomes in haploid spermatids, and its presence was
dependent upon histone H2A ubiquitin ligase RNF8. The
fact that transcription of sex chromosomes is down-
regulated at this stage indicates that Kcr may be part of an
epigenetic program that protects a subset of genes from
repression [30,49,50]. Western blot analysis of histonesfrom mouse, Drosophila, Caenorhabditis Elegans, and
Saccharomyces cerevisiae indicate that this modification is
conserved, raising the question as to what role this modifi-
cation may play in these organisms [30]. O-GlcNAcylation
of histones has also been studied heavily [36-38]. Sites
have been identified on serines or threonines on all four
core histones using MS, antibodies or lectin. It may be in-
volved in a couple of cellular processes, given that levels
increase during recovery from heat shock and levels fluc-
tuate in a cell-cyle-dependent manner [37]. The finding of
GlyNAcylation on H3S10, a residue commonly associated
with cell-cycle, may be particularly interesting [38]. O-
GlcNAcylation also may be important for crosstalk with
other modifications; H2BS112GlyNAc was found to pro-
mote H2B120Ub in Drosophila [36].
The possibility of numerous modifications occurring on
a single residue, like the preponderance of lysine PTMs
discussed above, raises questions about how these modifi-
cations are modulated either temporally or physically to
create a functional readout. Lysine residues susceptible to
ADP-ribosylation were identified with in vitro ribosylation
reactions and subsequent ETD fragmentation of histone
peptides. Residues in the N-termini of all four core his-
tones were found to be ADP-ribosylated, including histone
H4K16. Acetylation of H4K16 impeded in vitro
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tionship between these modifications [44]. Newly identi-
fied lysine 5-hydroxylation can block acetylation and
methylation by HAT p300 and methyltransferase SMYD3
during in vitro reactions [39]. A similar interplay may
occur at serine/threonine residues, where phosphoryl-
ation and O-GlcNAcylation reside. Serine/threonine
acetylation was discovered in adult mouse brain by MS
analysis and, although little is known, it may be of
interest due to its ability to compete with the other
modifications at these residues [32].
Characterization of novel post-translational modifications
As seen above, the discovery of a new modification raises
a variety of questions, including: (1) is the modification
evolutionarily conserved, (2) where in the genome is it
localized [51], how abundant is it, (4) does it occur in the
tails or globular domain of the histone, (5) what enzymes
are responsible for acquisition/removal, (6) does it cross-
talk with previously known modifications or histone
variants, (7) does it antagonize other PTMs or abrogate
binding of their reader proteins, and (8) what proteins
bind or 'read' the modification? The answers to these
questions lend insight into the biological function of
the PTM. Evolutionary conservation across species, for
example, indicates that it could be essential for a con-
served cellular process. Abundance of a modification, on
the other hand, may not be as indicative of its importance
since it has been observed that low-level modifications like
H3K4me3 play vital roles in biological processes such as
transcription [52]. The neighboring chromatin environ-
ment and the genomic localization of modifications to dis-
tinct regions may give more valuable information toward
gauging relevance and function.
New proteomic, genomic and chemical biology tech-
nologies have been developed or proposed to address the
above questions [7,12,53]. Analysis of DNA from chroma-
tin immunoprecipitation (ChIP) by high-throughput se-
quencing has become a standard tool for assessing PTM
localization within the genome [54]. More recently, native
ChIP methodologies have been developed to allow for
isolation and quantitative PTM analysis of histone pro-
teins, a technique referred to as chromatin immunopre-
cipitation with quantitative MS (ChIP-qMS) [51,55,56].
Native ChIPs can be performed with either a reader
protein or with a PTM-specific antibody to obtain the
associated histone codes and histone variants. For ex-
ample, FLAG-tagged bromodomain-containing Brd
proteins and chromodomain-containing HP1 proteins
were immunoprecipitated and the associated histone
was analyzed by MS. As expected, histones from Brd
ChIPs were enriched for active marks, while histones
from HP1 chips were enriched for silencing marks [56].
PTM ChIPs recently demonstrated that nucleosomes canbe asymmetrically modified, meaning that only one tail
within the octamer is modified. In the case of H3K36me3/
H3K4me3, symmetrical modification of both tails seems
to prevent PRC2 activity on H3K27, while asymmetric
modification allows for PRC2 activity resulting in
H3K27me3 on the opposing tail. The existence of
asymmetrical modifications adds another layer of com-
plexity to the histone code [51]. ChIP-qMS technolo-
gies have not been utilized for novel PTMs to date and,
due to their reliance on antibodies or tagged constructs,
these experiments are limited to known chromatin-
associated proteins or PTMs. While they can be viewed
as an improvement to whole genome quantitative PTM
experiments, they are still unable to focus on a particu-
lar chromatin locus or region.
In an attempt to surmount these limitations, Dejardin
and Kingston [57] and Byrum and colleagues [58] imple-
mented distinct methods for isolating specific genomic
loci and used MS to identify loci-specific proteins and
modified histone forms. Byrum and colleagues’ chromatin
affinity purification with MS method used a Lex-A bind-
ing site in the GAL1 locus of yeast to facilitate purification
of this locus and its associated proteins/histones during
silent and active states [58]. Dejardin and Kingston’s
proteomics of isolated chromatin method hybridized a
desthiobiotin labeled oligonucleotide to telomeric DNA
allowing for MS identification of telomere-associated
proteins in mammalian cells [57]. Capture of known
telomere-associated proteins using this protocol indicates
this is a valid approach for identifying chromatin-associated
proteins. These methods that can purify small regions of
chromatin may be helpful in the discovery of novel low-
level PTMs or PTMs that are restricted to particular areas
of the genome, both of which may be hard to detect in
whole genome analyses. They may also aid in identifying
new reader proteins.
To identify reader proteins that bind to specific modi-
fications, synthetically modified nucleosomes generated
by native protein ligation have been used as bait for
reader proteins. These stable isotope labeling of amino
acids in cell culture (SILAC) nucleosome affinity purifi-
cation experiments utilize SILAC labeling to compare
proteins bound to synthetic nucleosomes. Unmodified
and modified nucleosomes are incubated in light and
heavy SILAC-labeled nuclear lysates, respectively, and
the proteins isolated are mixed one to one. The light/
heavy ratio tells which proteins preferentially bind the
modified nucleosome and may act as a reader. Interest-
ingly, these data also provide insights into what proteins
PTMs may prevent from binding [59].
Most recently, SILAC labeling has also been utilized in
yeast to examine modifications that potentially crosstalk
with modifications on either H3K79 or H3K56. Yeast
mutant strains with amino acid substitutions to mimic
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one of which was grown in heavy media. By comparing
heavy/light ratios from a mutant and wild-type pair, the
impact of the modified state on H3K79 and H3K56
modifications could be determined. The analyses indicate
that modifications on all four core histones can effect
positively or negatively the modification levels on H3K56
and H3K79 [60].
Conclusions
A review of the recent literature reveals that novel sites
or types of histone PTMs are rapidly being discovered
and characterized, in part due to the powers of MS ana-
lysis and emerging proteomic, genomic and chemical
biology tools. The diversity seen in terms of location on
the nucleosome, genome localization and the cellular
processes in which they are involved highlight the
importance of histone PTMs to multiple fields of study
including cell biology, epigenetics, development and can-
cer biology. Since many of these modifications remain
poorly characterized, their discoveries open up new ave-
nues of research and promote the development of novel
technologies. The sheer number of novel modifications
begs the question how many more types of PTMs are
there remaining to be found?
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